• / Free eNewsletters & Magazine
  • / My Account
Home>Dr. Reddy’s Announces the Launch of Docetaxel Injection USP

Dr. Reddy’s Announces the Launch of Docetaxel Injection USP

3party Content

Mon, 24 Nov 2014

Dr. Reddy’s Laboratories (NYSE: RDY) announced today that is has launched Docetaxel Injection USP 20 mg/mL and 80 mg/4 mL a therapeutic equivalent generic version of TAXOTERE® (docetaxel Injection) in the US market on November 21, 2014. Dr. Reddy’s ANDA is approved by the United States Food & Drug
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.